AIDS Awareness AIDS Drug Overdose Crisis Sick Leave Practices AIDS Epidemic Substance Abuse Substance Abuse Issues Aging Population Chronic Diseases Child Health Euthanasia Debate Allergies Disability Smoking and Health Maternal Health Healthcare Access
A restructured Purdue Pharma will redirect $7.4 billion toward opioid treatment following the Sacklers' exit from U.S. opioid sales.